The Clinical Trials Network (CTNx) Partners with SelectIQ to Revolutionize Patient Recruitment for Clinical Research Sites

The Clinical Trials Network (CTNx) Partners with SelectIQ to Revolutionize Patient Recruitment for Clinical Research Sites

 

The Clinical Trials Network (CTNx) has forged a strategic partnership with SelectIQ to transform patient recruitment for clinical research sites. SelectIQ offers an innovative software that seamlessly integrates with a practice’s Electronic Medical Records (EMR) system, harnessing the power of artificial intelligence to analyze patient records. This technology flags individuals whose medical history aligns with the criteria for participation in a clinical trial, ranking them based on their likelihood of participation.

CTNx enhances this process by providing additional support to research sites. Their team conducts outreach, calling and pre-screening potential study candidates to ensure they meet the necessary qualifications. Utilizing an Institutional Review Board (IRB) approved script, qualified candidates are identified and referred to the research site’s study coordinator for an in-person screening and study enrollment.

Christopher Petek, Chief Operating Officer of The Clinical Trials Network, expressed enthusiasm about the partnership, stating, “Patient enrollment is paramount to the success of any study and research site. We are excited to leverage this cutting-edge technology to empower our research sites, streamlining the identification and enrollment of qualified patients in clinical trials.”

Ethan Bond, Chief Executive Officer of SelectIQ, shared that “SelectIQ empowers healthcare providers to connect their patients with relevant clinical trial opportunities. CTNx is a natural collaborator given their success bringing trials into community healthcare practices. We’re proud to support their important work.”

Research sites keen on optimizing their clinical trial enrollment processes can learn more about CTNx’s offerings by visiting their website at www.thectnx.com or requesting to schedule a live demo through the following online form

 

About CTNx

The Clinical Trials Network (CTNx) is a network of private practice research sites committed to enhancing access and diversity in clinical trials. Since its establishment in 2018, CTNx has facilitated the opening of over 90 research sites spanning various medical specialties, including Gastroenterology, Ophthalmology, Dermatology, Allergy/Immunology, Pulmonology, Neurology/Psychiatry, Cardiology, Rheumatology, Endocrinology, and Women’s Health.

CTNx is renowned for its comprehensive centralized administrative support and its in-house program for identifying and training clinical research coordinators, assisting both novice and seasoned investigators in navigating the clinical trial landscape. For more information, visit www.thectnx.com.

About SelectIQ

SelectIQ is a Provider Activation Platform that reduces burden on healthcare providers who wish to make clinical trial opportunities available to their patients. Founded by industry veterans from data and AI firm Palantir, SelectIQ brings a wealth of expertise in clinical data analytics, security, and governance.

The team has a proven track record of developing robust software solutions for esteemed organizations, including intelligence agencies, academic medical centers, and leading pharmaceutical companies. Notably, SelectIQ’s founders played instrumental roles in crafting the data governance systems safeguarding clinical data within the National Institutes of Health’s COVID research platform and the United Kingdom’s National Health Service (NHS). For more information, visit www.selectiq.com.

Interested in SelectIQ and working with us ? Contact us today!

Get in Touch
Linkedin

The Clinical Trials Network (CTNx) Adopts VersaTrial to Alleviate Tech Overload and Empower Research Teams

image with Christopher Petek the Clinical Trials Newtwork president. Banner with quote. Blue and white.

The Clinical Trials Network (CTNx) Adopts VersaTrial to Alleviate Tech Overload and Empower Research Teams

VersaTrial, the clinical research site enablement and engagement platform, today announced a collaboration with The Clinical Trials Network (CTNx). CTNx has chosen to adopt VersaTrial’s Study Organizer, aiming to elevate research productivity and efficiency across its expansive network of over 75 specialty-based private practice research sites.

VersaTrial will provide CTNx’s research staff with a streamlined solution to consolidate and access important study information such as technology portals, login credentials, and external contacts for each clinical trial. Its intelligent internet browser extension will enable users to quickly reference study-specific information directly and seamlessly within other clinical  technologies like EDC, CTMS, and ePRO systems. 

CTNx will be joining a rapidly expanding global community of research sites, hospitals, and academic medical centers who report increased productivity, reduced frustration, and greater job satisfaction thanks to VersaTrial.

“VersaTrial was specifically designed to reduce the technological burdens often associated with clinical research,” said Mike Wenger, founder and CEO of VersaTrial. “We fully support CTNx’s vision to simplify and make clinical research more accessible for private practices. I’m delighted that our solution can provide CTNx study teams the much-needed extra time to concentrate on accuracy, adherence to protocols, and most importantly, patient care.”

Christopher Petek, President of CTNx, echoed this sentiment: “We’re thrilled about our new partnership with VersaTrial and look forward to rolling out their study organizer to all the research sites in The Clinical Trials Network (CTNx). At CTNx we’re constantly looking for ways to make the lives of clinical research coordinators and investigators easier. VersaTrial does exactly that, helping organize study information which saves time and improves site staff productivity.”

“At CTNx we’re constantly looking for ways to make the lives of clinical research coordinators and investigators easier. VersaTrial does exactly that, helping organize study information which saves time and improves site staff productivity.”


The Clinical Trials Network currently boasts 75 network sites, over 11,000 enrolled patients, partnerships with more than 60 sponsors, and over 400 clinical trials. Their focus areas include Gastroenterology, Ophthalmology, Dermatology, Allergy/Immunology, Neurology, and Women’s Health. 

About CTNx

The Clinical Trials Network (CTNx) is a specialty-based network of private practice research sites dedicated to expanding access and representation in clinical trials. Since its inception in 2018, CTNx has opened over 75 sites with networks in Gastroenterology, Ophthalmology, Dermatology, Allergy/Immunology, Neurology, and Women’s Health. CTNx has built its reputation on assisting naïve investigators through the clinical trial space with its fully integrated centralized administrative support and in-house clinical research coordinator identification and training program. For more information, visit www.thectnx.com.

About VersaTrial

VersaTrial is the all-in-one site portal that lets Sponsors and CROs improve clinical trial speed, quality, and collaboration. Enabling sites to spend more time with patients and less time navigating technology systems unlocks faster trials with fewer mistakes, wider tech adoption, and stronger site relationships. Only VersaTrial’s clinical trial site engagement platform provides Sponsors and CROs with real-time operational insights, bi-directional communication, and access management alerts to ensure measurable partner oversight and quality execution. Learn more at https://www.versatrial.io.

Become an Investigator

Virgo and CTNx Partner to Power GI Clinical Trials

Virgo and CTNx Partner. Network of 30+ high-qualify research sites will leverage endoscopy Al platform to expand and accelerate enrollment in gastroenterology clinical trials. Blue and white banner.

Virgo and CTNx Partner to Power GI Clinical Trials

Virgo Surgical Video Solutions, Inc. (“Virgo”) and The Clinical Trials Network (“CTNx”) have today announced a strategic partnership to expand and accelerate the identification, selection, and enrollment of patients in gastrointestinal (GI) clinical trials across CTNx’s expansive network of 30+ GI clinical trial sites, using Virgo’s endoscopy data capture and artificial intelligence platform. Virgo and CTNx is an exciting partnership!

The Clinical Trials Network brings physicians together to create a leading source of high-quality research sites to present to trial sponsors. Virgo’s cloud-based, HIPAA- and SOC-2-compliant platform allows gastroenterologists to automatically record, store, and manage endoscopy videos without interrupting clinical workflows. Artificial intelligence tools developed by Virgo analyze complex inclusion and exclusion criteria set forth by trial sponsors, ultimately making clinical trials more accessible to a larger, more diverse set of patients suffering from GI conditions such as Ulcerative Colitis and Crohn’s Disease.

“We feel honored to be working with the CTNx team. We are both impressed by their network and excited to deploy our cloud-based products to their membership in pursuit of greater access, equity, and inclusion in GI clinical trials,” said Ian Strug, Co-founder and Chief Revenue Officer of Virgo. “We believe this partnership will yield heightened study opportunities across a broad spectrum of diseases and device trials, in addition to adding standard of care capabilities to the everyday work of patient care.”

“We are beyond excited to be working with the Virgo team and their best-in-class AI GI technology,” said Keith Friedenberg, CEO of CTNx. “We feel this partnership is an exciting moment for the future of clinical trial recruitment. This accelerates our mission of bringing clinical trials to community physicians and their patients.”

About Virgo 

 

Virgo Surgical Video Solutions provides the leading cloud video capture, management, and artificial intelligence analysis platform for endoscopic medicine. Over 80 academic, integrated, and private practice healthcare providers use Virgo’s HIPAA- and SOC-2-compliant platform to advance patient care through video-based research and training initiatives. In 2021, Virgo launched a suite of tools called Virgo Trials, which help pharmaceutical trial sponsors and their participating trial sites accelerate patient recruitment and shorten the overall enrollment period for trials. For more information, visit virgosvs.com.

About CTNx

 

The Clinical Trials Network (CTNx) is a specialty-based network of private practice research sites dedicated to expanding access and representation in clinical trials. Since its inception in 2018, CTNx has opened over 70 sites with networks in Gastroenterology, Ophthalmology, Dermatology, Allergy/Immunology, Neurology, and Women’s Health. CTNx has built its reputation on assisting naïve investigators through the clinical trial space with its fully integrated centralized administrative support and in-house clinical research coordinator identification and training program. For more information, visit www.thectnx.com.

Get involved in research (GI)